Direxion Daily S&P Biotech Bear 3X ETF ETF Prediction and Forecast [LABD]

AI-generated source summary

The Direxion Daily S&P Biotech Bear 3X ETF (LABD) exhibits a bearish trend, with multiple indicators suggesting further downside. Technical analysis points to key resistance levels at $30.20 and $33.85, while a breakdown above these levels could signal a shift. The ETF has experienced significant volatility, with a negative score and a sell candidate ranking. The overall outlook for LABD remains bearish, with potential for further decline in the short to medium term.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   12 Nov 2025, 04:48 UTC

   The analyst published the original source item.

2. First prediction resolved

   20 Nov 2025, 15:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   20 Nov 2025, 15:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:12 UTC

   Tahlil Plus began monitoring the extracted predictions.